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Abstract
Background: In accordance with German neurosurgical and neurological consensus recommendations, lead
placements for deep brain stimulation (DBS) in patients with Parkinson’s disease (PD) are usually performed
with the patient awake and in “medication off” state. This allows for optimal lead position adjustment according
to the clinical response to intraoperative test stimulation. However, exacerbation of Parkinsonian symptoms
after withdrawal of dopaminergic medication may endanger the patient by inducing severe “off” state motor
phenomena. In particular, this can be a problem in awake craniotomies utilizing intraoperative airway
management and resuscitation.
Case presentation: We report the case of a PD patient with progressive orofacial and neck muscle dystonia
resulting in laryngeal spasm during DBS lead placement. This led to upper airway compromise and asphyxia,
requiring resuscitation.
Conclusions: Laryngeal spasms may occur as a rare “off” state motor complication in patients with PD. Other
potential causes of intraoperative difficulties breathing include bilateral vocal cord palsy, positional asphyxia,
and silent aspiration. In our practice, we have adjusted our medication regimen and now allow patients to
receive their standard dopaminergic medication until the morning of surgery. Neurologists and neurosurgeons
performing lead placement procedures for PD should be aware of this rare but unsafe condition to most
optimized treatment.
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Background
Deep brain stimulation (DBS) of the subthalamic nucleus
(STN) is indicated for patients with severe motor
symptoms in advanced Parkinson’s disease (PD) [1].
In accordance with current consensus recommenda-
tions, the majority of neurologists and neurosurgeons
prefer awake craniotomies [2, 3]; although some
groups [4] perform this surgery under general anesthesia.
Awake surgery ensures optimal lead placement rather
than relying solely on anatomical landmarks and electro-
physiological data gained by microelectrode recordings
[5]. The effect of intraoperative macrostimulation on
PD symptoms should correspond to the patient’s pre-
operative response to levodopa. Furthermore, intraope-
rative test stimulation with the patient awake allows
assessment of potential stimulation-associated side effects
with consecutive adaption of lead position. In preparation
for surgery, dopaminergic medication is usually with-
drawn approximately twelve hours before surgery. Thus,
patients are in their “medication off” state when entering
the operating theater. “Off” state PD symptoms may be
exacerbated by exhaustion.
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In DBS patients undergoing awake lead placement,
loss of airway is critical, as the patient’s head is placed in
the stereotactic frame, which is attached to the operating
table.
In this case report we highlight the rare complication
of severe intraoperative laryngeal spasm with secondary
asphyxia in a patient with PD during DBS placement,
likely due to withdrawal of dopaminergic medication.
Case presentation
The patient is a 59-year-old man diagnosed with PD at
the age of 49 years. Fluctuations with recurring “off”
states and peak dose dyskinesias had severely diminished
the patient’s quality of life. Thus, the patient was deemed
a candidate for bilateral subthalamic DBS. Multidiscip-
linary evaluation with 75 % positive response in the
standardized levodopa test, exclusion of cognitive decline
or psychiatric comorbitity, and absence of structural brain
damage potentially relevant to the lead placement led to
the unanimous decision for DBS placement. When
decision was made to proceed to surgery the medication
consisted of 1112.5 mg of levodopa and 150 mg of
piribedil. There was no history of orofacial or cervical
dystonia.
In the “on” state the patient was alert without any
signs of psychiatric comorbidity. Neuropsychological
testing was adequate. No cranial nerve deficits were found
and swallowing was normal. Gait and postural stability
was normal with minimal rigidity in the neck and right
arm. Coordinative motor skills such as rapid pro- and
supination were restricted in the left hand. Dyskinesias
were evident with moderate impairment. In the “off” state
after the medication was held for 12 h, the patient showed
mild dysarthria and dysphonia, resting tremor of the right
arm and leg, as well as slight action tremor in the right
hand. Rigidity was severe in the neck, marked in the right,
and mild on the left side. Motor skills of the hands
were markedly impaired. Gait was slow but unaided
and comprised of by intermittent freezing; there was mild
dystonic posturing of the right foot. There were no signs
of laryngeal spasms, however.
On the day before surgery, the last dose of dopami-
nergic medication was administered at 07:00 p.m., the
bedtime dose of levodopa was held to facilitate intra-
operative testing. On the day of the operation, the patient
underwent placement of the stereotactic frame under local
anaesthesia around 09:00 a.m. After planning standard
STN coordinates and trajectories, the patient was placed
in a semi-sitting position on the O.R. table, with the frame
attached to the table. At the patient’s request, the head
was slightly flexed anteriorly for comfort. The left elec-
trode was placed uneventfully. When performing the bur
hole on the right side, the patient complained of cramping
in the neck and facial muscles as well as difficulties
breathing although at that point, pulse oximetry showed
good saturation readings at ≥95 %. He progressed to
dystonic dysarthria [6]. Microelectrode recordings had
already been done and macroelectrode test stimulation
was about to begin, when the patient showed high-pitched
inspiratory stridor. Pulse oximetry showed decreasing
oxygen saturation at 02:15 p.m. and, shortly thereafter,
narrow complex tachycardia was noted. Within a minute,
the patient became unresponsive. Cardiac resuscitation
was initiated and the patient was fiberoptically intubated
after removal of the front bar of the stereotactic frame.
During fiberoptic intubation laryngeal spasm was con-
firmed visually. A transthoracic echocardiogram obtained
immediately after successful resuscitation showed no car-
diac pathology or any air bubbles. Stimulation using the
implanted lead to resolve the symptoms was not possible
as at that time the lead was subcutaneously tunnelled
with no impulse generator attached. The right permanent
electrode was placed without further testing according to
microelectrode recordings. 50 mg levodopa was adminis-
tered over a nasogastric tube every two hours during the
subsequent postoperative period. Postoperative head CT
scan done immediately after the procedure was normal.
The patient was transferred to the intensive care unit and
was extubated at 02:00 p.m. the following day without any
neurological deficit or signs of laryngeal spasms. By then,
the nasogastric tube was discontinued and the preopera-
tive medication was resumed. Cardiac workup was nega-
tive. The impulse generator was implanted 7 days later
and the patient showed good symptom control of PD.
Conclusion
The aforementioned complication has not been described
before. We suspect laryngeal spasms developed in the
course of the dystonic symptoms due to the lack of
dopaminergic stimulation as a cause.
Throughout the literature, the terms “laryngeal dys-
tonia” and “laryngeal spasm” are occasionally used syn-
onymously, especially in the context of underlying
neurological disease, although laryngospasms can also
be elicited by local inflammatory reactions, regardless
of a dystonic disorder. Both conditions were associated
with PD and other neurological conditions, such as
multiple system atrophy, and can subsequently lead to
upper airway obstruction [7].
Effects of PD on respiratory function are well-known.
Dyspnea as a symptom in PD was first described in 1958
[8]. Without naming the likely diagnosis of laryngeal
spasm due to a laryngeal dystonia, levodopa-responsive
upper airway obstruction was characterized further in
1989. Featuring flow-volume loops on a patient with
PD, the author clearly demonstrated a significant airway
compromise in the “medication off” state, with impro-
vement of forced vital capacity after administration of
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levodopa [9]. Further clinical cases can be found in the
literature. One of these reports describes the case of a
71-year-old man with PD undergoing elective bowel
surgery. He developed upper airway obstruction requi-
ring re-intubation after discontinuation of his Parkinson
medication [10]. The second case was a 61-year-old PD
patient also required re-intubation for laryngospasm after
uneventful elective abdominal surgery [11]. In both
cases, dopaminergic medication was resumed thereafter
and symptoms completely resolved.
Other possible explanations for upper airway compro-
mise in PD patients include rarely laryngeal spasms in-
duced by neuroleptics and the well known symptom of
silent aspiration [12–15]. It seems unlikely, however, that
silent aspiration played a role in the pathogenesis of
rapidly progressive difficulties breathing and secondary
asphyxia, as seen in our patient.
A recent forensic publication draws some attention to
the aspect of positional asphyxia in predisposed patients.
In a retrospective analysis of patients with positional
asphyxia being the cause of death, the authors report
on a patient with severe PD and progressive supranuclear
palsy and clinical disability to extend her head by her own,
leading to difficulties breathing in the flexed position that
she was found in [16]. Although highly unlikely, antecollis
head position in the semi-sitting position with the frame
rigidly attached to the operating table should be within
the scope of possible attributing factors of breathing
difficulties in awake surgery.
Furthermore, we have considered a stimulation induced
dystonic reaction upon lead insertion and test stimulation
on the left side that gradually developed over the course
of the remaining procedure. However, after reviewing the
macrostimulation protocol of the left side, we did not
experience any dystonic reaction, neither upon electrode
placement nor stimulation. Hence, we do not believe,
that any effect will be elicited with a detached stimulator
thereafter.
We hypothesize that upper airway obstruction due to
“off” state induced laryngeal spasm eventually necessi-
tated resuscitation in our patient. Levodopa withdrawal
of 12 h in the context of preoperative evaluation was
likely not long enough to result in a clinically relevant
laryngeal spasm. However, as the prolonged levodopa
withdrawal of over 19 h may enhance exhaustion and
thus severity of “off” state symptoms by impaired sleep
the night before, we propose to allow levodopa medica-
tion until six hours before surgery. This may help avoid
the very severe “off” state this patient experienced. So
far, we have not had any difficulties with clinical testing
during surgery, as clinical symptoms were fully present
during time of macrostimulation. Any change of voice
or breathing pattern during DBS procedures should alert
neurologist, neurosurgeons, and anaesthesiologists to
consider life-threatening laryngeal spasm. We now utilize
a neutral position of the head when attaching the stereo-
tactic frame to the operating table. This has become
important in patients that prefer to have the head of
bed somewhat higher as sliding down in the course of
the operation will increase flexion of the head.
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